Cardiol Therapeutics (CRDL) Stock Chart & Stock Price History $1.34 +0.03 (+1.89%) As of 10:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cardiol Therapeutics Stock Price Performance The Cardiol Therapeutics (CRDL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 31.38%, with a year-to-date return of 5.08%. In the past month, the stock has increased 8.47%, reflecting recent market activity. As of the latest close, Cardiol Therapeutics traded at $1.32 with a market cap of $109.10 million and volume of 143,822 shares. Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.61%1 Month Performance+8.47%3 Month Performance+45.93%Year-To-Date Performance+5.08%1 Year Performance-31.38% CRDL Stock Chart for Wednesday, July, 2, 2025 CRDL Chart by TradingView Cardiol Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$1.36$1.32-2.94%$1.40$1.30143,822 shs$109.10 million06/30/2025$1.41$1.36-3.55%$1.42$1.32209,951 shs$112.40 million06/27/2025$1.47$1.41-4.08%$1.50$1.4072,055 shs$116.54 million06/26/2025$1.45$1.47+1.38%$1.49$1.41142,827 shs$121.50 million06/25/2025$1.34$1.45+8.21%$1.48$1.35395,411 shs$119.84 million06/24/2025$1.28$1.34+4.69%$1.36$1.29126,875 shs$110.75 million06/23/2025$1.24$1.28+3.23%$1.32$1.24162,865 shs$105.79 million06/20/2025$1.32$1.24-6.06%$1.37$1.22291,778 shs$102.49 million06/19/2025$1.32$1.32$1.37$1.31183,965 shs$109.10 million06/18/2025$1.37$1.32-3.65%$1.37$1.31183,965 shs$109.10 million Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$1.43$1.37-4.20%$1.44$1.36194,617 shs$113.23 million06/16/2025$1.46$1.43-2.05%$1.49$1.42114,519 shs$118.19 million06/13/2025$1.44$1.46+1.39%$1.50$1.38177,007 shs$120.67 million06/12/2025$1.40$1.44+2.86%$1.45$1.35289,748 shs$119.02 million06/11/2025$1.45$1.40-3.45%$1.45$1.39171,860 shs$115.71 million06/10/2025$1.44$1.45+0.69%$1.49$1.40347,819 shs$119.84 million06/09/2025$1.41$1.44+2.13%$1.45$1.40168,774 shs$118.96 million06/06/2025$1.38$1.41+2.17%$1.43$1.35173,836 shs$116.48 million06/05/2025$1.45$1.38-4.83%$1.49$1.36500,278 shs$114 million06/04/2025$1.31$1.45+10.69%$1.45$1.30506,742 shs$119.78 million06/03/2025$1.24$1.31+5.65%$1.34$1.21292,900 shs$108.22 million06/02/2025$1.25$1.24-0.40%$1.28$1.18234,177 shs$102.44 million Related Companies ORKA Stock Price Chart RAPP Stock Price Chart RGNX Stock Price Chart ERAS Stock Price Chart FULC Stock Price Chart ITOS Stock Price Chart BNTC Stock Price Chart RVNC Stock Price Chart UPXI Stock Price Chart ABVX Stock Price Chart Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRDL) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
